Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1649 (LINC01649) is a human long intergenic non-coding RNA (lincRNA) gene. LincRNAs are transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and are not translated into proteins. Instead, they play regulatory roles at the transcriptional and post-transcriptional levels, including chromatin modification, regulation of gene expression, and occasionally acting as molecular scaffolds or decoys. LincRNAs may function in a tissue-specific manner and are often involved in the fine-tuning of gene expression, although the precise biological role of LINC01649 itself remains largely uncharacterized[1][3][5]. Unlike classic therapeutic targets such as enzymes or receptors, lincRNAs generally serve as regulatory molecules rather than direct drug targets. If LINC01649 is of specific interest as a therapeutic or diagnostic target, there is as yet no evidence that it has been directly implicated in a particular disease or targeted by drug therapies in the scientific literature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1649 (LINC01649).